Left Atrial Myxoma on FDG-PET/CT

被引：0

作者：

Gheysens, Olivier ^{[1
]}

Cornillie, Jasmien ^{[2
]}

Voigt, Jens-Uwe ^{[3
]}

Bogaert, Jan ^{[4
]}

Westhovens, Rene ^{[2
]}

机构：

[1] Katholieke Univ Leuven Hosp, Dept Nucl Med, Louvain, Belgium

[2] Katholieke Univ Leuven Hosp, Dept Rheumatol, Louvain, Belgium

[3] Katholieke Univ Leuven Hosp, Dept Cardiol, Louvain, Belgium

[4] Katholieke Univ Leuven Hosp, Dept Radiol, B-3000 Louvain, Belgium

来源：

CLINICAL NUCLEAR MEDICINE | 2013年 / 38卷 / 11期

关键词：

atrial myxoma; cardiac tumor; FDG-PET/CT; multimodality imaging; CARDIAC MYXOMA; TUMORS;

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A 56-year-old woman with rheumatoid factor-positive rheumatoid arthritis underwent FDG-PET/CT because of fatigue, fever, coughing, and weight loss for several months. FDG-PET/CT solely revealed a mildly hypermetabolic hypodense area in the left atrium. Subsequently, transthoracic echocardiography and contrast-enhanced MRI showed a left atrial pedunculated soft tissue mass suggestive for myxoma, with histological confirmation. Myocardial involvement by tumors is rare, and FDG-PET/CT has been very useful for identifying cardiac metastases. However, very few cases have been reported using FDG-PET/CT for detecting primary cardiac tumors, but as shown here, abnormal focal myocardial uptake should trigger further morphological assessment.

引用

页码：E421 / E422

页数：2

共 9 条

[1] Defection of cardiac myxoma by F-18 FDG PET [J].

Agostini, D ;

Babatasi, G ;

Galateau, F ;

Grollier, G ;

Potier, JC ;

Bouvard, G .

CLINICAL NUCLEAR MEDICINE, 1999, 24 (03) :159-160

[2] A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin [J].

Bleeker-Rovers, Chantal P. ;

Vos, Fidel J. ;

Mudde, Aart H. ;

Dofferhoff, Anton S. M. ;

de Geus-Oei, Lioe-Fee ;

Rijnders, Anton J. ;

Krabbe, Paul F. M. ;

Corstens, Frans H. M. ;

van der Meer, Jos W. M. ;

Oyen, Wim J. G. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (05) :694-703

[3] Embolic Potential of Cardiac Tumors and Outcome After Resection A Case-Control Study [J].

ElBardissi, Andrew W. ;

Dearani, Joseph A. ;

Daly, Richard C. ;

Mullany, Charles J. ;

Orszulak, Thomas A. ;

Puga, Francisco J. ;

Schaff, Hartzell V. .

STROKE, 2009, 40 (01) :156-162

[4] From the archives of the AFIP - Cardiac myxoma: Imaging features in 83 patients [J].

Grebenc, ML ;

Rosado-de-Christenson, ML ;

Green, CE ;

Burke, AP ;

Galvin, JR .

RADIOGRAPHICS, 2002, 22 (03) :673-689

[5]

LAM KY, 1993, ARCH PATHOL LAB MED, V117, P1027

[6] Does Cancer That Occurs During or After Anti-Tumor Necrosis Factor Therapy Have a Worse Prognosis? A National Assessment of Overall and Site-Specific Cancer Survival in Rheumatoid Arthritis Patients Treated With Biologic Agents [J].

Raaschou, Pauline ;

Simard, Julia F. ;

Neovius, Martin ;

Askling, Johan .

ARTHRITIS AND RHEUMATISM, 2011, 63 (07) :1812-1822

[7]

SALCEDO EE, 1992, CURR PROB CARDIOLOGY, V17, P75

[8]

SEINO Y, 1993, BRIT HEART J, V69, P565

[9] Changing management of cardiac myxoma based on a series of 40 cases with long-term follow-up [J].

Selkane, C ;

Amahzoune, B ;

Chavanis, N ;

Raisky, O ;

Robin, J ;

Ninet, J ;

Obadia, JF .

ANNALS OF THORACIC SURGERY, 2003, 76 (06) :1935-1938

← 1 →